Global Drug of Abuse (DOA) Testing Consumables Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Drug of Abuse (DOA) Testing Consumables will have significant change from previous year. According to our (LP Information) latest study, the global Drug of Abuse (DOA) Testing Consumables market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Drug of Abuse (DOA) Testing Consumables market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Drug of Abuse (DOA) Testing Consumables market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug of Abuse (DOA) Testing Consumables market, reaching US$ million by the year 2028. As for the Europe Drug of Abuse (DOA) Testing Consumables landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug of Abuse (DOA) Testing Consumables players cover Siemens AG, Merck, Roche, and Thermo Fisher Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug of Abuse (DOA) Testing Consumables market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Drug of Abuse (DOA) Testing Consumables will have significant change from previous year. According to our (LP Information) latest study, the global Drug of Abuse (DOA) Testing Consumables market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Drug of Abuse (DOA) Testing Consumables market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Drug of Abuse (DOA) Testing Consumables market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug of Abuse (DOA) Testing Consumables market, reaching US$ million by the year 2028. As for the Europe Drug of Abuse (DOA) Testing Consumables landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug of Abuse (DOA) Testing Consumables players cover Siemens AG, Merck, Roche, and Thermo Fisher Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug of Abuse (DOA) Testing Consumables market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Rapid Test Kits
- Assay Kits and Reagents
- Others
- Hospitals
- Laboratories
- Workplace
- At-Home
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Siemens AG
- Merck
- Roche
- Thermo Fisher Scientific
- Bio-Rad
- Abbott
- Quest Diagnostics
- Psychemedics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drug of Abuse (DOA) Testing Consumables by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drug of Abuse (DOA) Testing Consumables by Country/Region, 2017, 2022 & 2028
2.2 Drug of Abuse (DOA) Testing Consumables Segment by Type
2.2.1 Rapid Test Kits
2.2.2 Assay Kits and Reagents
2.2.3 Others
2.3 Drug of Abuse (DOA) Testing Consumables Sales by Type
2.3.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
2.3.2 Global Drug of Abuse (DOA) Testing Consumables Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drug of Abuse (DOA) Testing Consumables Sale Price by Type (2017-2022)
2.4 Drug of Abuse (DOA) Testing Consumables Segment by Application
2.4.1 Hospitals
2.4.2 Laboratories
2.4.3 Workplace
2.4.4 At-Home
2.4.5 Others
2.5 Drug of Abuse (DOA) Testing Consumables Sales by Application
2.5.1 Global Drug of Abuse (DOA) Testing Consumables Sale Market Share by Application (2017-2022)
2.5.2 Global Drug of Abuse (DOA) Testing Consumables Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drug of Abuse (DOA) Testing Consumables Sale Price by Application (2017-2022)
3 GLOBAL DRUG OF ABUSE (DOA) TESTING CONSUMABLES BY COMPANY
3.1 Global Drug of Abuse (DOA) Testing Consumables Breakdown Data by Company
3.1.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales by Company (2020-2022)
3.1.2 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Company (2020-2022)
3.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue by Company (2020-2022)
3.2.1 Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2020-2022)
3.2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company (2020-2022)
3.3 Global Drug of Abuse (DOA) Testing Consumables Sale Price by Company
3.4 Key Manufacturers Drug of Abuse (DOA) Testing Consumables Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug of Abuse (DOA) Testing Consumables Product Location Distribution
3.4.2 Players Drug of Abuse (DOA) Testing Consumables Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG OF ABUSE (DOA) TESTING CONSUMABLES BY GEOGRAPHIC REGION
4.1 World Historic Drug of Abuse (DOA) Testing Consumables Market Size by Geographic Region (2017-2022)
4.1.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue by Geographic Region
4.2 World Historic Drug of Abuse (DOA) Testing Consumables Market Size by Country/Region (2017-2022)
4.2.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue by Country/Region
4.3 Americas Drug of Abuse (DOA) Testing Consumables Sales Growth
4.4 APAC Drug of Abuse (DOA) Testing Consumables Sales Growth
4.5 Europe Drug of Abuse (DOA) Testing Consumables Sales Growth
4.6 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Growth
5 AMERICAS
5.1 Americas Drug of Abuse (DOA) Testing Consumables Sales by Country
5.1.1 Americas Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022)
5.1.2 Americas Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022)
5.2 Americas Drug of Abuse (DOA) Testing Consumables Sales by Type
5.3 Americas Drug of Abuse (DOA) Testing Consumables Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug of Abuse (DOA) Testing Consumables Sales by Region
6.1.1 APAC Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022)
6.1.2 APAC Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022)
6.2 APAC Drug of Abuse (DOA) Testing Consumables Sales by Type
6.3 APAC Drug of Abuse (DOA) Testing Consumables Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug of Abuse (DOA) Testing Consumables by Country
7.1.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022)
7.1.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022)
7.2 Europe Drug of Abuse (DOA) Testing Consumables Sales by Type
7.3 Europe Drug of Abuse (DOA) Testing Consumables Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumables by Country
8.1.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022)
8.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Type
8.3 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug of Abuse (DOA) Testing Consumables
10.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
10.4 Industry Chain Structure of Drug of Abuse (DOA) Testing Consumables
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug of Abuse (DOA) Testing Consumables Distributors
11.3 Drug of Abuse (DOA) Testing Consumables Customer
12 WORLD FORECAST REVIEW FOR DRUG OF ABUSE (DOA) TESTING CONSUMABLES BY GEOGRAPHIC REGION
12.1 Global Drug of Abuse (DOA) Testing Consumables Market Size Forecast by Region
12.1.1 Global Drug of Abuse (DOA) Testing Consumables Forecast by Region (2023-2028)
12.1.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug of Abuse (DOA) Testing Consumables Forecast by Type
12.7 Global Drug of Abuse (DOA) Testing Consumables Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Siemens AG
13.1.1 Siemens AG Company Information
13.1.2 Siemens AG Drug of Abuse (DOA) Testing Consumables Product Offered
13.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Siemens AG Main Business Overview
13.1.5 Siemens AG Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Drug of Abuse (DOA) Testing Consumables Product Offered
13.2.3 Merck Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Drug of Abuse (DOA) Testing Consumables Product Offered
13.3.3 Roche Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Offered
13.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Bio-Rad
13.5.1 Bio-Rad Company Information
13.5.2 Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Offered
13.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bio-Rad Main Business Overview
13.5.5 Bio-Rad Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Drug of Abuse (DOA) Testing Consumables Product Offered
13.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Quest Diagnostics
13.7.1 Quest Diagnostics Company Information
13.7.2 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Offered
13.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Quest Diagnostics Main Business Overview
13.7.5 Quest Diagnostics Latest Developments
13.8 Psychemedics
13.8.1 Psychemedics Company Information
13.8.2 Psychemedics Drug of Abuse (DOA) Testing Consumables Product Offered
13.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Psychemedics Main Business Overview
13.8.5 Psychemedics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Drug of Abuse (DOA) Testing Consumables by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Drug of Abuse (DOA) Testing Consumables by Country/Region, 2017, 2022 & 2028
2.2 Drug of Abuse (DOA) Testing Consumables Segment by Type
2.2.1 Rapid Test Kits
2.2.2 Assay Kits and Reagents
2.2.3 Others
2.3 Drug of Abuse (DOA) Testing Consumables Sales by Type
2.3.1 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
2.3.2 Global Drug of Abuse (DOA) Testing Consumables Revenue and Market Share by Type (2017-2022)
2.3.3 Global Drug of Abuse (DOA) Testing Consumables Sale Price by Type (2017-2022)
2.4 Drug of Abuse (DOA) Testing Consumables Segment by Application
2.4.1 Hospitals
2.4.2 Laboratories
2.4.3 Workplace
2.4.4 At-Home
2.4.5 Others
2.5 Drug of Abuse (DOA) Testing Consumables Sales by Application
2.5.1 Global Drug of Abuse (DOA) Testing Consumables Sale Market Share by Application (2017-2022)
2.5.2 Global Drug of Abuse (DOA) Testing Consumables Revenue and Market Share by Application (2017-2022)
2.5.3 Global Drug of Abuse (DOA) Testing Consumables Sale Price by Application (2017-2022)
3 GLOBAL DRUG OF ABUSE (DOA) TESTING CONSUMABLES BY COMPANY
3.1 Global Drug of Abuse (DOA) Testing Consumables Breakdown Data by Company
3.1.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales by Company (2020-2022)
3.1.2 Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Company (2020-2022)
3.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue by Company (2020-2022)
3.2.1 Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2020-2022)
3.2.2 Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company (2020-2022)
3.3 Global Drug of Abuse (DOA) Testing Consumables Sale Price by Company
3.4 Key Manufacturers Drug of Abuse (DOA) Testing Consumables Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug of Abuse (DOA) Testing Consumables Product Location Distribution
3.4.2 Players Drug of Abuse (DOA) Testing Consumables Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG OF ABUSE (DOA) TESTING CONSUMABLES BY GEOGRAPHIC REGION
4.1 World Historic Drug of Abuse (DOA) Testing Consumables Market Size by Geographic Region (2017-2022)
4.1.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue by Geographic Region
4.2 World Historic Drug of Abuse (DOA) Testing Consumables Market Size by Country/Region (2017-2022)
4.2.1 Global Drug of Abuse (DOA) Testing Consumables Annual Sales by Country/Region (2017-2022)
4.2.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue by Country/Region
4.3 Americas Drug of Abuse (DOA) Testing Consumables Sales Growth
4.4 APAC Drug of Abuse (DOA) Testing Consumables Sales Growth
4.5 Europe Drug of Abuse (DOA) Testing Consumables Sales Growth
4.6 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Growth
5 AMERICAS
5.1 Americas Drug of Abuse (DOA) Testing Consumables Sales by Country
5.1.1 Americas Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022)
5.1.2 Americas Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022)
5.2 Americas Drug of Abuse (DOA) Testing Consumables Sales by Type
5.3 Americas Drug of Abuse (DOA) Testing Consumables Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug of Abuse (DOA) Testing Consumables Sales by Region
6.1.1 APAC Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022)
6.1.2 APAC Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022)
6.2 APAC Drug of Abuse (DOA) Testing Consumables Sales by Type
6.3 APAC Drug of Abuse (DOA) Testing Consumables Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug of Abuse (DOA) Testing Consumables by Country
7.1.1 Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022)
7.1.2 Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022)
7.2 Europe Drug of Abuse (DOA) Testing Consumables Sales by Type
7.3 Europe Drug of Abuse (DOA) Testing Consumables Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumables by Country
8.1.1 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022)
8.1.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022)
8.2 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Type
8.3 Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug of Abuse (DOA) Testing Consumables
10.3 Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
10.4 Industry Chain Structure of Drug of Abuse (DOA) Testing Consumables
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug of Abuse (DOA) Testing Consumables Distributors
11.3 Drug of Abuse (DOA) Testing Consumables Customer
12 WORLD FORECAST REVIEW FOR DRUG OF ABUSE (DOA) TESTING CONSUMABLES BY GEOGRAPHIC REGION
12.1 Global Drug of Abuse (DOA) Testing Consumables Market Size Forecast by Region
12.1.1 Global Drug of Abuse (DOA) Testing Consumables Forecast by Region (2023-2028)
12.1.2 Global Drug of Abuse (DOA) Testing Consumables Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug of Abuse (DOA) Testing Consumables Forecast by Type
12.7 Global Drug of Abuse (DOA) Testing Consumables Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Siemens AG
13.1.1 Siemens AG Company Information
13.1.2 Siemens AG Drug of Abuse (DOA) Testing Consumables Product Offered
13.1.3 Siemens AG Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Siemens AG Main Business Overview
13.1.5 Siemens AG Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Drug of Abuse (DOA) Testing Consumables Product Offered
13.2.3 Merck Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Drug of Abuse (DOA) Testing Consumables Product Offered
13.3.3 Roche Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Information
13.4.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Offered
13.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Thermo Fisher Scientific Main Business Overview
13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Bio-Rad
13.5.1 Bio-Rad Company Information
13.5.2 Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Offered
13.5.3 Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bio-Rad Main Business Overview
13.5.5 Bio-Rad Latest Developments
13.6 Abbott
13.6.1 Abbott Company Information
13.6.2 Abbott Drug of Abuse (DOA) Testing Consumables Product Offered
13.6.3 Abbott Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Abbott Main Business Overview
13.6.5 Abbott Latest Developments
13.7 Quest Diagnostics
13.7.1 Quest Diagnostics Company Information
13.7.2 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Offered
13.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Quest Diagnostics Main Business Overview
13.7.5 Quest Diagnostics Latest Developments
13.8 Psychemedics
13.8.1 Psychemedics Company Information
13.8.2 Psychemedics Drug of Abuse (DOA) Testing Consumables Product Offered
13.8.3 Psychemedics Drug of Abuse (DOA) Testing Consumables Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Psychemedics Main Business Overview
13.8.5 Psychemedics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug of Abuse (DOA) Testing Consumables Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drug of Abuse (DOA) Testing Consumables Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rapid Test Kits
Table 4. Major Players of Assay Kits and Reagents
Table 5. Major Players of Others
Table 6. Global Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 7. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 8. Global Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & ($ million)
Table 9. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2022)
Table 10. Global Drug of Abuse (DOA) Testing Consumables Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 12. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 13. Global Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022)
Table 14. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2022)
Table 15. Global Drug of Abuse (DOA) Testing Consumables Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Drug of Abuse (DOA) Testing Consumables Sales by Company (2020-2022) & (K Units)
Table 17. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Company (2020-2022)
Table 18. Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company (2020-2022)
Table 20. Global Drug of Abuse (DOA) Testing Consumables Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Drug of Abuse (DOA) Testing Consumables Producing Area Distribution and Sales Area
Table 22. Players Drug of Abuse (DOA) Testing Consumables Products Offered
Table 23. Drug of Abuse (DOA) Testing Consumables Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug of Abuse (DOA) Testing Consumables Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Geographic Region (2017-2022)
Table 28. Global Drug of Abuse (DOA) Testing Consumables Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Drug of Abuse (DOA) Testing Consumables Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country/Region (2017-2022)
Table 32. Global Drug of Abuse (DOA) Testing Consumables Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
Table 35. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2017-2022)
Table 36. Americas Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2017-2022)
Table 38. Americas Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 39. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 40. Americas Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 41. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 42. APAC Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022) & (K Units)
Table 43. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2017-2022)
Table 44. APAC Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2017-2022)
Table 46. APAC Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 47. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 48. APAC Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 49. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 50. Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
Table 51. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2017-2022)
Table 52. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2017-2022)
Table 54. Europe Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 55. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 56. Europe Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 57. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Drug of Abuse (DOA) Testing Consumables
Table 67. Key Market Challenges & Risks of Drug of Abuse (DOA) Testing Consumables
Table 68. Key Industry Trends of Drug of Abuse (DOA) Testing Consumables
Table 69. Drug of Abuse (DOA) Testing Consumables Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Drug of Abuse (DOA) Testing Consumables Distributors List
Table 72. Drug of Abuse (DOA) Testing Consumables Customer List
Table 73. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Drug of Abuse (DOA) Testing Consumables Sales Market Forecast by Region
Table 75. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Drug of Abuse (DOA) Testing Consumables Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Drug of Abuse (DOA) Testing Consumables Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Drug of Abuse (DOA) Testing Consumables Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Application (2023-2028)
Table 93. Siemens AG Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 94. Siemens AG Drug of Abuse (DOA) Testing Consumables Product Offered
Table 95. Siemens AG Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Siemens AG Main Business
Table 97. Siemens AG Latest Developments
Table 98. Merck Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Drug of Abuse (DOA) Testing Consumables Product Offered
Table 100. Merck Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Roche Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Drug of Abuse (DOA) Testing Consumables Product Offered
Table 105. Roche Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Thermo Fisher Scientific Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 109. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Offered
Table 110. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Thermo Fisher Scientific Main Business
Table 112. Thermo Fisher Scientific Latest Developments
Table 113. Bio-Rad Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Offered
Table 115. Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Bio-Rad Main Business
Table 117. Bio-Rad Latest Developments
Table 118. Abbott Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 119. Abbott Drug of Abuse (DOA) Testing Consumables Product Offered
Table 120. Abbott Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Abbott Main Business
Table 122. Abbott Latest Developments
Table 123. Quest Diagnostics Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 124. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Offered
Table 125. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Quest Diagnostics Main Business
Table 127. Quest Diagnostics Latest Developments
Table 128. Psychemedics Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 129. Psychemedics Drug of Abuse (DOA) Testing Consumables Product Offered
Table 130. Psychemedics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Psychemedics Main Business
Table 132. Psychemedics Latest Developments
Table 1. Drug of Abuse (DOA) Testing Consumables Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Drug of Abuse (DOA) Testing Consumables Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Rapid Test Kits
Table 4. Major Players of Assay Kits and Reagents
Table 5. Major Players of Others
Table 6. Global Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 7. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 8. Global Drug of Abuse (DOA) Testing Consumables Revenue by Type (2017-2022) & ($ million)
Table 9. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2022)
Table 10. Global Drug of Abuse (DOA) Testing Consumables Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 12. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 13. Global Drug of Abuse (DOA) Testing Consumables Revenue by Application (2017-2022)
Table 14. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application (2017-2022)
Table 15. Global Drug of Abuse (DOA) Testing Consumables Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Drug of Abuse (DOA) Testing Consumables Sales by Company (2020-2022) & (K Units)
Table 17. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Company (2020-2022)
Table 18. Global Drug of Abuse (DOA) Testing Consumables Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company (2020-2022)
Table 20. Global Drug of Abuse (DOA) Testing Consumables Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Drug of Abuse (DOA) Testing Consumables Producing Area Distribution and Sales Area
Table 22. Players Drug of Abuse (DOA) Testing Consumables Products Offered
Table 23. Drug of Abuse (DOA) Testing Consumables Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug of Abuse (DOA) Testing Consumables Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Geographic Region (2017-2022)
Table 28. Global Drug of Abuse (DOA) Testing Consumables Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Drug of Abuse (DOA) Testing Consumables Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country/Region (2017-2022)
Table 32. Global Drug of Abuse (DOA) Testing Consumables Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
Table 35. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2017-2022)
Table 36. Americas Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2017-2022)
Table 38. Americas Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 39. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 40. Americas Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 41. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 42. APAC Drug of Abuse (DOA) Testing Consumables Sales by Region (2017-2022) & (K Units)
Table 43. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2017-2022)
Table 44. APAC Drug of Abuse (DOA) Testing Consumables Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Region (2017-2022)
Table 46. APAC Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 47. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 48. APAC Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 49. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 50. Europe Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
Table 51. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2017-2022)
Table 52. Europe Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2017-2022)
Table 54. Europe Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 55. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 56. Europe Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 57. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Drug of Abuse (DOA) Testing Consumables
Table 67. Key Market Challenges & Risks of Drug of Abuse (DOA) Testing Consumables
Table 68. Key Industry Trends of Drug of Abuse (DOA) Testing Consumables
Table 69. Drug of Abuse (DOA) Testing Consumables Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Drug of Abuse (DOA) Testing Consumables Distributors List
Table 72. Drug of Abuse (DOA) Testing Consumables Customer List
Table 73. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Drug of Abuse (DOA) Testing Consumables Sales Market Forecast by Region
Table 75. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Drug of Abuse (DOA) Testing Consumables Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Drug of Abuse (DOA) Testing Consumables Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Drug of Abuse (DOA) Testing Consumables Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Drug of Abuse (DOA) Testing Consumables Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Drug of Abuse (DOA) Testing Consumables Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share Forecast by Application (2023-2028)
Table 93. Siemens AG Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 94. Siemens AG Drug of Abuse (DOA) Testing Consumables Product Offered
Table 95. Siemens AG Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Siemens AG Main Business
Table 97. Siemens AG Latest Developments
Table 98. Merck Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Drug of Abuse (DOA) Testing Consumables Product Offered
Table 100. Merck Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Roche Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Drug of Abuse (DOA) Testing Consumables Product Offered
Table 105. Roche Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Thermo Fisher Scientific Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 109. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Product Offered
Table 110. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Thermo Fisher Scientific Main Business
Table 112. Thermo Fisher Scientific Latest Developments
Table 113. Bio-Rad Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Rad Drug of Abuse (DOA) Testing Consumables Product Offered
Table 115. Bio-Rad Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Bio-Rad Main Business
Table 117. Bio-Rad Latest Developments
Table 118. Abbott Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 119. Abbott Drug of Abuse (DOA) Testing Consumables Product Offered
Table 120. Abbott Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Abbott Main Business
Table 122. Abbott Latest Developments
Table 123. Quest Diagnostics Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 124. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Product Offered
Table 125. Quest Diagnostics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Quest Diagnostics Main Business
Table 127. Quest Diagnostics Latest Developments
Table 128. Psychemedics Basic Information, Drug of Abuse (DOA) Testing Consumables Manufacturing Base, Sales Area and Its Competitors
Table 129. Psychemedics Drug of Abuse (DOA) Testing Consumables Product Offered
Table 130. Psychemedics Drug of Abuse (DOA) Testing Consumables Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Psychemedics Main Business
Table 132. Psychemedics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug of Abuse (DOA) Testing Consumables
Figure 2. Drug of Abuse (DOA) Testing Consumables Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug of Abuse (DOA) Testing Consumables Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drug of Abuse (DOA) Testing Consumables Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rapid Test Kits
Figure 10. Product Picture of Assay Kits and Reagents
Figure 11. Product Picture of Others
Figure 12. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type in 2021
Figure 13. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2022)
Figure 14. Drug of Abuse (DOA) Testing Consumables Consumed in Hospitals
Figure 15. Global Drug of Abuse (DOA) Testing Consumables Market: Hospitals (2017-2022) & (K Units)
Figure 16. Drug of Abuse (DOA) Testing Consumables Consumed in Laboratories
Figure 17. Global Drug of Abuse (DOA) Testing Consumables Market: Laboratories (2017-2022) & (K Units)
Figure 18. Drug of Abuse (DOA) Testing Consumables Consumed in Workplace
Figure 19. Global Drug of Abuse (DOA) Testing Consumables Market: Workplace (2017-2022) & (K Units)
Figure 20. Drug of Abuse (DOA) Testing Consumables Consumed in At-Home
Figure 21. Global Drug of Abuse (DOA) Testing Consumables Market: At-Home (2017-2022) & (K Units)
Figure 22. Drug of Abuse (DOA) Testing Consumables Consumed in Others
Figure 23. Global Drug of Abuse (DOA) Testing Consumables Market: Others (2017-2022) & (K Units)
Figure 24. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Figure 25. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application in 2021
Figure 26. Drug of Abuse (DOA) Testing Consumables Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company in 2021
Figure 28. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Geographic Region in 2021
Figure 30. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2017-2022)
Figure 31. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country/Region in 2021
Figure 32. Americas Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 33. Americas Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 34. APAC Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 35. APAC Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 36. Europe Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 37. Europe Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 40. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country in 2021
Figure 41. Americas Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country in 2021
Figure 42. United States Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region in 2021
Figure 47. APAC Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Regions in 2021
Figure 48. China Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country in 2021
Figure 55. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country in 2021
Figure 56. Germany Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country in 2021
Figure 63. Egypt Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Drug of Abuse (DOA) Testing Consumables in 2021
Figure 69. Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
Figure 70. Industry Chain Structure of Drug of Abuse (DOA) Testing Consumables
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Drug of Abuse (DOA) Testing Consumables
Figure 2. Drug of Abuse (DOA) Testing Consumables Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug of Abuse (DOA) Testing Consumables Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Drug of Abuse (DOA) Testing Consumables Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Drug of Abuse (DOA) Testing Consumables Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Rapid Test Kits
Figure 10. Product Picture of Assay Kits and Reagents
Figure 11. Product Picture of Others
Figure 12. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Type in 2021
Figure 13. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Type (2017-2022)
Figure 14. Drug of Abuse (DOA) Testing Consumables Consumed in Hospitals
Figure 15. Global Drug of Abuse (DOA) Testing Consumables Market: Hospitals (2017-2022) & (K Units)
Figure 16. Drug of Abuse (DOA) Testing Consumables Consumed in Laboratories
Figure 17. Global Drug of Abuse (DOA) Testing Consumables Market: Laboratories (2017-2022) & (K Units)
Figure 18. Drug of Abuse (DOA) Testing Consumables Consumed in Workplace
Figure 19. Global Drug of Abuse (DOA) Testing Consumables Market: Workplace (2017-2022) & (K Units)
Figure 20. Drug of Abuse (DOA) Testing Consumables Consumed in At-Home
Figure 21. Global Drug of Abuse (DOA) Testing Consumables Market: At-Home (2017-2022) & (K Units)
Figure 22. Drug of Abuse (DOA) Testing Consumables Consumed in Others
Figure 23. Global Drug of Abuse (DOA) Testing Consumables Market: Others (2017-2022) & (K Units)
Figure 24. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Application (2017-2022)
Figure 25. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Application in 2021
Figure 26. Drug of Abuse (DOA) Testing Consumables Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Company in 2021
Figure 28. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Geographic Region in 2021
Figure 30. Global Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region (2017-2022)
Figure 31. Global Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country/Region in 2021
Figure 32. Americas Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 33. Americas Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 34. APAC Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 35. APAC Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 36. Europe Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 37. Europe Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue 2017-2022 ($ Millions)
Figure 40. Americas Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country in 2021
Figure 41. Americas Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country in 2021
Figure 42. United States Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Drug of Abuse (DOA) Testing Consumables Sales Market Share by Region in 2021
Figure 47. APAC Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Regions in 2021
Figure 48. China Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country in 2021
Figure 55. Europe Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country in 2021
Figure 56. Germany Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Drug of Abuse (DOA) Testing Consumables Revenue Market Share by Country in 2021
Figure 63. Egypt Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Drug of Abuse (DOA) Testing Consumables Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Drug of Abuse (DOA) Testing Consumables in 2021
Figure 69. Manufacturing Process Analysis of Drug of Abuse (DOA) Testing Consumables
Figure 70. Industry Chain Structure of Drug of Abuse (DOA) Testing Consumables
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
